These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 24148256)

  • 21. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
    Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
    Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
    HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment neutrophil to lymphocyte ratio is a predictor of prognosis in endometrial cancer.
    Haruma T; Nakamura K; Nishida T; Ogawa C; Kusumoto T; Seki N; Hiramatsu Y
    Anticancer Res; 2015 Jan; 35(1):337-43. PubMed ID: 25550569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
    BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
    Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
    J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.
    Sukato DC; Tohme S; Chalhoub D; Han K; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
    J Vasc Interv Radiol; 2015 Jun; 26(6):816-24.e1. PubMed ID: 25824315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study.
    Zaragoza J; Kervarrec T; Touzé A; Avenel-Audran M; Beneton N; Esteve E; Wierzbicka Hainaut E; Aubin F; Machet L; Samimi M
    J Am Acad Dermatol; 2016 Oct; 75(4):712-721.e1. PubMed ID: 27544490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study.
    Nakashima H; Matsuoka Y; Yoshida R; Nagata M; Hirosue A; Kawahara K; Sakata J; Arita H; Hiraki A; Nakayama H
    BMC Cancer; 2016 Jan; 16():41. PubMed ID: 26812901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
    Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
    Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.
    Mano Y; Shirabe K; Yamashita Y; Harimoto N; Tsujita E; Takeishi K; Aishima S; Ikegami T; Yoshizumi T; Yamanaka T; Maehara Y
    Ann Surg; 2013 Aug; 258(2):301-5. PubMed ID: 23774313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.
    Cho H; Hur HW; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
    Cancer Immunol Immunother; 2009 Jan; 58(1):15-23. PubMed ID: 18414853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
    Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.